Ammonia n-13
Ammonia N-13 is a radioactive diagnostic agent used in medical imaging, such as PET scans, to help evaluate blood flow in the heart or other organs. It is administered intravenously as an injection with a strength of up to 260 mCi/mL. Manufactured by The Methodist Hospital Research Institute, it is available as a prescription drug under ANDA215083. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Ammonia N-13 is a radioactive diagnostic agent used in medical imaging, such as PET scans, to help evaluate blood flow in the heart or other organs. It is administered intravenously as an injection with a strength of up to 260 mCi/mL. Manufactured by The Methodist Hospital Research Institute, it is available as a prescription drug under ANDA215083. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Ammonia n-13",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Ammonia n-13 — ANDA 211740 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211740"
}
]
|
| identifier | ANDA211740 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-safety",
"fda",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Ammonia n-13 |